Sign in

CIK 0001600620 · Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981231763
Phone
250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$546,373
in 2 filings

Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$546K Chief Legal Officer sold 5% of stake

Reading 54 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-18 MacKay-Dunn R. Hector Director Option exercise +8,733 19,733
2023-05-18 MacKay-Dunn R. Hector Director Option exercise · Restricted Stock Units −8,733 0
2023-05-18 Leversage Jill Director Option exercise +8,733 14,033
2023-05-18 Leversage Jill Director Option exercise · Restricted Stock Units −8,733 0
2023-03-02 Robertson Stephen P. EVP, General Counsel Sale −19,644 $8.78 $172K 303,122
2023-03-02 Miller Joseph M Chief Financial Officer Sale −11,398 $8.78 $100K 331,112
2023-03-02 Greenleaf Peter Chief Executive Officer Sale −33,047 $8.78 $290K 982,671
2023-03-02 MILNE GEORGE M JR Director Purchase +20,000 $8.91 $178K 70,000
2023-03-02 Donley Matthew Maxwell EVP, Ops & Strategy Grant or award +271,134 403,141
2023-03-02 Miller Joseph M Chief Financial Officer Grant or award +229,421 342,510
2023-03-02 Miller Joseph M Chief Financial Officer Sale −11,296 $8.94 $101K 331,214
2023-03-02 Robertson Stephen P. EVP, General Counsel Grant or award +204,810 322,766
2023-03-02 Robertson Stephen P. EVP, General Counsel Sale −19,402 $8.94 $173K 303,364
2023-03-02 Martin Michael Robert Chief Business Officer Grant or award +107,202 259,162
2023-03-02 Habig Scott Michael Chief Commercial Officer Grant or award +170,188 312,719
2023-03-02 Knappertz Volker EVP, Research and Development Grant or award +191,462 344,274
2023-03-02 Greenleaf Peter Chief Executive Officer Grant or award +667,407 1,015,718
2023-03-02 Greenleaf Peter Chief Executive Officer Sale −32,750 $8.94 $293K 982,968
2022-11-21 Donley Matthew Maxwell Ex VP, Internal Operations Purchase +10,000 $4.66 $47K 27,927
2022-11-09 Habig Scott Michael Chief Commercial Officer Purchase +5,000 $5.02 $25K 5,000

Page 9 of 10 · 197 trades